CN Stock MarketDetailed Quotes
002038 Beijing Sl Pharmaceutical
- 7.71
- +0.09+1.18%
Market Closed Dec 12 15:00 CST
7.92BMarket Cap96.38P/E (TTM)
7.72High7.57Low203.29KlotVolume7.64Open7.62Pre Close155.86MTurnover2.39%Turnover Ratio18.99P/E (Static)1.03BShares10.4852wk High1.41P/B6.57BFloat Cap6.1652wk Low8.38Limit Up851.52MShs Float32.18Historical High6.86Limit Down1.97%Amplitude-1.41Historical Low0.15Dividend TTM7.67Avg Price76.67KlotAsk1.95%Div YieldTTM100Lot Size121.14KlotBid
Beijing Sl Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -30.40%540.56M | -32.81%392.06M | -17.35%245.12M | -3.03%1.02B | -6.09%776.63M | 5.29%583.51M | 8.02%296.58M | -13.55%1.05B | -9.46%826.97M | -11.26%554.22M |
| Operating revenue | -30.40%540.56M | -32.81%392.06M | -17.35%245.12M | -3.03%1.02B | -6.09%776.63M | 5.29%583.51M | 8.02%296.58M | -13.55%1.05B | -9.46%826.97M | -11.26%554.22M |
| Other operating revenue | ---- | -54.85%2.8M | ---- | -23.87%12.98M | ---- | 7.17%6.2M | ---- | 6.23%17.05M | ---- | -15.83%5.78M |
| Total operating cost | -16.35%461.95M | -26.35%261.7M | -22.80%136.62M | -10.92%765.79M | -11.99%552.26M | -9.84%355.34M | -8.30%176.98M | -10.44%859.65M | -7.54%627.46M | -15.66%394.12M |
| Operating cost | 12.89%170.78M | -7.45%89.87M | 40.80%58.01M | 19.64%187.79M | 15.72%151.28M | 12.24%97.1M | -14.18%41.2M | -14.50%156.96M | -6.41%130.73M | -11.48%86.52M |
| Operating tax surcharges | -27.53%5.07M | -32.33%4.13M | -31.45%1.6M | 9.72%10.09M | 16.23%7M | 27.28%6.1M | 77.39%2.33M | -18.03%9.2M | -18.42%6.02M | -18.38%4.79M |
| Operating expense | -56.00%91.22M | -65.43%48.8M | -76.95%17.04M | -36.36%271.6M | -37.94%207.31M | -30.13%141.16M | -13.36%73.9M | -11.39%426.8M | -4.96%334.03M | -6.15%202.02M |
| Administration expense | 5.00%101.97M | 13.11%65.91M | 23.63%34.21M | 11.75%134.05M | 27.47%97.11M | 22.42%58.27M | 8.97%27.67M | 15.73%119.96M | 5.70%76.18M | -7.98%47.6M |
| Financial expense | 48.27%-6.03M | 47.24%-4.43M | 27.19%-2.29M | 0.45%-14.84M | 29.45%-11.65M | 23.22%-8.4M | 26.77%-3.14M | 9.19%-14.91M | -30.52%-16.51M | -23.18%-10.93M |
| -Interest expense (Financial expense) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -54.48%102.56K | -55.36%83.92K | -75.97%55.94K |
| -Interest Income (Financial expense) | 40.43%-6.57M | 34.65%-4.84M | 17.76%-2.6M | 6.56%-14.21M | 39.57%-11.02M | 32.66%-7.41M | 26.83%-3.16M | 9.69%-15.2M | -40.63%-18.24M | -20.40%-11M |
| Research and development | -2.24%98.93M | -6.03%57.42M | -19.87%28.05M | 9.56%177.11M | 4.33%101.2M | -4.71%61.1M | -6.05%35.01M | -17.59%161.65M | -19.61%97M | -39.29%64.12M |
| Credit Impairment Loss | 47.41%-13.44M | 52.30%-13.38M | 71.33%-4.63M | 19.95%-25.57M | -33.58%-25.56M | -3.90%-28.04M | -87.25%-16.16M | -21.69%-31.94M | 3.26%-19.14M | -92.36%-26.99M |
| Asset Impairment Loss | ---- | ---- | ---- | 43.64%-1.02M | ---- | ---- | ---- | ---1.81M | ---- | ---- |
| Other net revenue | -192.25%-110.93M | -191.56%-111.88M | -133.56%-37.34M | 209.47%225.3M | 138.58%120.24M | 835.31%122.19M | 810.42%111.25M | -64.06%72.8M | -79.32%50.4M | -92.67%13.06M |
| Fair value change income | -244.51%-121.66M | -209.60%-118.5M | -143.00%-44.05M | 863.35%205.21M | 577.08%84.19M | 1,395.76%108.11M | 449.85%102.45M | -81.25%21.3M | -92.48%12.43M | -106.60%-8.34M |
| Invest income | -66.02%18.52M | -60.77%14.68M | -63.56%7.46M | -56.44%34.26M | 6.80%54.5M | -11.70%37.43M | 21.02%20.47M | -17.59%78.64M | -37.65%51.03M | -20.01%42.39M |
| -Including: Investment income associates | ---- | ---- | ---- | 23.49%12.27M | ---- | ---- | ---- | -43.30%9.93M | -239.40%-28.26K | 8.30%-20.99K |
| Asset deal income | 260.68%1.14K | 171.40%507.6 | ---- | -93.51%13.33K | -101.19%-710.91 | -101.19%-710.91 | ---- | -93.63%205.4K | -98.08%59.77K | --59.77K |
| Other revenue | -20.45%5.66M | 13.11%5.31M | -13.50%3.88M | 93.66%12.41M | 18.42%7.12M | -21.12%4.69M | -15.88%4.49M | -61.38%6.41M | -53.96%6.01M | -53.70%5.95M |
| Operating profit | -109.38%-32.32M | -94.72%18.48M | -69.18%71.16M | 81.48%477.87M | 37.89%344.61M | 102.33%350.36M | 250.33%230.85M | -42.45%263.32M | -47.76%249.91M | -48.38%173.16M |
| Add:Non operating Income | -100.00%1.12 | -100.00%0.02 | 162,944.57%1.5K | -9.89%27.16K | 191.66%28.24K | 172,025,600.00%17.2K | 9,100.00%0.92 | -93.67%30.14K | 65.49%9.68K | -97.62%0.01 |
| Less:Non operating expense | 144,744.90%4.85M | 167.52%2.94K | ---- | 225.43%13M | -22.81%3.35K | -74.54%1.1K | --1.1K | 2,070.80%4M | -79.00%4.34K | -76.63%4.32K |
| Total profit | -110.78%-37.17M | -94.73%18.48M | -69.18%71.16M | 79.25%464.89M | 37.90%344.64M | 102.35%350.37M | 250.32%230.85M | -43.35%259.35M | -47.76%249.92M | -48.37%173.16M |
| Less:Income tax cost | -168.36%-19.42M | -130.13%-10.3M | -94.92%1.48M | 61.04%49.94M | 88.70%28.41M | 245.84%34.19M | 699.88%29.17M | -15.07%31.01M | -67.13%15.06M | -73.85%9.89M |
| Net profit | -105.61%-17.75M | -90.90%28.78M | -65.45%69.68M | 81.73%414.96M | 34.64%316.23M | 93.66%316.18M | 223.99%201.68M | -45.80%228.34M | -45.71%234.86M | -45.14%163.27M |
| Net profit from continuing operation | -105.61%-17.75M | -90.90%28.78M | -65.45%69.68M | 81.73%414.96M | 34.64%316.23M | 93.66%316.18M | 223.99%201.68M | -45.80%228.34M | -45.71%234.86M | -45.14%163.27M |
| Less:Minority Profit | 24.63%-1.01M | 18.17%-805.85K | -83.96%-458.81K | 71.39%-1.73M | 56.59%-1.34M | 52.18%-984.79K | 76.18%-249.4K | -31.40%-6.06M | 7.49%-3.09M | 47.92%-2.06M |
| Net profit of parent company owners | -105.27%-16.74M | -90.67%29.59M | -65.27%70.13M | 77.77%416.69M | 33.46%317.57M | 91.84%317.16M | 219.02%201.93M | -44.97%234.4M | -45.42%237.95M | -45.17%165.33M |
| Earning per share | ||||||||||
| Basic earning per share | -105.27%-0.0163 | -90.32%0.03 | -65.00%0.07 | 78.26%0.41 | 33.46%0.3091 | 93.75%0.31 | 233.33%0.2 | -43.90%0.23 | -45.42%0.2316 | -45.49%0.16 |
| Diluted earning per share | -105.27%-0.0163 | -90.32%0.03 | -65.00%0.07 | 78.26%0.41 | 33.46%0.3091 | 93.75%0.31 | 233.33%0.2 | -43.90%0.23 | -45.42%0.2316 | -45.49%0.16 |
| Other composite income | -3.89%12.81M | 1,322.33%13.33M | 134.02%1.56M | 164.06%1.76M | ||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -6.19%12.81M | ---- | ---- | ---- | 1,144.28%13.65M | 128.98%1.33M | 143.76%1.59M |
| Other composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -250.18%-326.06K | --231.37K | -80.36%172.85K |
| Total composite income | -105.61%-17.75M | -90.90%28.78M | -65.45%69.68M | 77.00%427.77M | 33.76%316.23M | 91.59%316.18M | 221.45%201.68M | -42.49%241.67M | -44.76%236.42M | -44.03%165.03M |
| Total composite income of parent company owners | -105.27%-16.74M | -90.67%29.59M | -65.27%70.13M | 73.15%429.5M | 32.72%317.57M | 90.02%317.16M | 216.57%201.93M | -41.58%248.06M | -44.53%239.28M | -43.97%166.91M |
| Total composite income of minority owners | 24.63%-1.01M | 18.17%-805.85K | -83.96%-458.81K | 72.85%-1.73M | 53.07%-1.34M | 47.80%-984.79K | 76.18%-249.4K | -45.31%-6.39M | 14.43%-2.86M | 38.63%-1.89M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
